29 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
, and/or supply chain; the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property … supply chain for our preclinical and clinical trial supplies. If our current or future suppliers, whether for raw materials, drug substance, or drug
ARS
7ax9i 1ni1tmxn46jum
28 Apr 23
Annual report to shareholders
7:03am
S-3ASR
m8ixi6
10 Nov 21
Automatic shelf registration
5:19pm
8-K
EX-99.2
3qj9y qr1wfgf8
11 Aug 21
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
hu34t8p
11 Aug 21
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
4:07pm
424B4
mgyfbkq6m 3mkd71lfq
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
mzw7q f4jx9lfq433x6t
19 May 21
Draft registration statement
12:00am